Massaro, M.; Ciani, R.; Grossi, G.; Cavallaro, G.; de Melo Barbosa, R.; Falesiedi, M.; Fortuna, C.G.; Carbone, A.; Schenone, S.; Sánchez-Espejo, R.;
et al. Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-d]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment. Pharmaceutics 2024, 16, 1428.
https://doi.org/10.3390/pharmaceutics16111428
AMA Style
Massaro M, Ciani R, Grossi G, Cavallaro G, de Melo Barbosa R, Falesiedi M, Fortuna CG, Carbone A, Schenone S, Sánchez-Espejo R,
et al. Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-d]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment. Pharmaceutics. 2024; 16(11):1428.
https://doi.org/10.3390/pharmaceutics16111428
Chicago/Turabian Style
Massaro, Marina, Rebecca Ciani, Giancarlo Grossi, Gianfranco Cavallaro, Raquel de Melo Barbosa, Marta Falesiedi, Cosimo G. Fortuna, Anna Carbone, Silvia Schenone, Rita Sánchez-Espejo,
and et al. 2024. "Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-d]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment" Pharmaceutics 16, no. 11: 1428.
https://doi.org/10.3390/pharmaceutics16111428
APA Style
Massaro, M., Ciani, R., Grossi, G., Cavallaro, G., de Melo Barbosa, R., Falesiedi, M., Fortuna, C. G., Carbone, A., Schenone, S., Sánchez-Espejo, R., Viseras, C., Vago, R., & Riela, S.
(2024). Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-d]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment. Pharmaceutics, 16(11), 1428.
https://doi.org/10.3390/pharmaceutics16111428
